Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation

Area of Science:

• Immunology
• T cell biology
• Vaccinology

Background:

• Mannose receptor-mediated targeting can enhance antigen presentation.
• Understanding T cell effector function is crucial for vaccine development.

Purpose of the Study:

• To investigate the impact of mannosylated ovalbumin peptide (M-OVA(323-339)) on T cell responses in mice.
• To determine if M-OVA(323-339) affects T cell effector functions and overall immune response.

Main Methods:

• Administration of M-OVA(323-339) in complete adjuvant to mice.
• Monitoring of CFSE-labeled ovalbumin peptide-specific TCR transgenic CD4(+) T cells.
• Assessment of T cell expansion, recirculation, CD62L expression, IFN-gamma production, IgG2a levels, and delayed-type hypersensitivity (DTH) responses.

Main Results:

• M-OVA(323-339) immunization enhanced antigen presentation and induced normal T cell clonal expansion, recirculation, and CD62L expression.
• Despite normal proliferation, T cells exhibited poor effector functions, including minimal IFN-gamma production and low IgG2a levels.
• Diminished inflammatory responses were observed, with reduced T cell blast and macrophage infiltration.
• M-OVA(323-339) challenge abrogated the DTH response even in mice with pre-existing functional effector T cells.

Conclusions:

• Mannosylated peptides induce T cell proliferation but result in impaired T helper 1 (Th1) cell effector functions.
• M-OVA(323-339) can suppress the activity of pre-existing effector T cells, negatively impacting immune responses.